Jacob Gottlieb, MD, PRMIA, CFA, is an entrepreneur in the financial industry. He entered this industry in 2001 after earning his medical degree. With his background as a trained medical doctor, he invests strictly in healthcare firms. He started out at Sanford C. Bernstein & Co., LLC, and worked there for two years as an analyst who would help determine what healthcare companies to invest in.
He first became a portfolio manager at Merlin and then Jacob Gottlieb went on to co-found Balyasny Asset Management, L.P. (BAM). It was at BAM that he established his reputation as a savvy hedge fund manager as his fund made large gains. He then founded Visium Asset Management, LLC. This was a highly successful hedge fund but, unfortunately, a number of his executives turned out to be engaged doing insider trading. The government authorities cleared his name but, nevertheless, he had to wind down operations and close up shop.
His new hedge fund firm is called Altium Capital and it is based in New York City. Jacob Gottlieb continues to do what he does best which is invest in cutting-edge healthcare firms that are creating exciting treatments for diseases. The first company he chose to invest in was Oramed Pharmaceutical in which he took a 5.61 percent stake. They are developing oral treatments for diabetes which has been a long sought-out goal in the healthcare field. They now have three products on the market and a lot of exciting things under development.
Jacob Gottlieb also invested in Amarin which as an office in Bedminster, NJ, and is based in Dublin, Ireland. They are developing treatments for cardiovascular disease and have one product, Vascepa, that has been FDA-approved. He also invested in Oragenics which does Replacement Therapy, developing treatments that replace negative bacteria with positive ones.